Sponsor intelligence · OTHER
Clinical trials sponsored by
Abramson Cancer Center At Penn Medicine.
Real, source-linked trial activity for Abramson Cancer Center At Penn Medicine: 3 tracked trials, by phase and status, newest first. New trials = pipeline expansion = CRO, site, and reagent demand.
✔ Verified against the public NIH RePORTER & ClinicalTrials.gov records as of Sep 23, 2026. Source-linked, daily-refreshed.
PHASE2 1N/A 1NA 1
Newest Abramson Cancer Center At Penn Medicine trials
| Posted | Trial | Phase | Status | |
|---|---|---|---|---|
| 1d ago | Saruparib in HRDsig+ Solid Tumors | Ph 2 | NOT_YET_RECRUITING | ↗ |
| 15d ago | DNP-MRSI of HCC Metabolism to Predict Therapeutic Response | N/A | NOT_YET_RECRUITING | ↗ |
| 22d ago | Prognostic Biomarkers for Patients With Human Papillomavirus (HPV) Pos | NA | NOT_YET_RECRUITING | ↗ |
Get this lane pushed to you the day a new grant or trial lands
Free email digest + a daily new-funding feed (JSON / MCP / webhook) of newly-awarded NIH grants and newly-registered clinical trials for Abramson Cancer Center At Penn Medicine (trial sponsor). Watch institutions, PIs, sponsors, and topics. Newly-funded labs = new buyers, today.